Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery

Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.

Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

Study targets intravitreal injections for AMD, PCR risks

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.